Theratechnologies Plans Financial Results and Business Call
Theratechnologies to Unveil Financial Results
Theratechnologies Inc. has announced an exciting upcoming event for its stakeholders as the company prepares to report its fourth quarter and full year financial results for fiscal 2024. This highly anticipated announcement is set for February 26, 2025, at 8:30 a.m. ET. As a prominent specialty biopharmaceutical firm, Theratechnologies focuses on bringing innovative therapies to market, aiming to set new standards of care.
Management Team Involved
This conference call will feature key figures from Theratechnologies, including the President and CEO, Paul Lévesque. He will be joined by leading executives such as Philippe Dubuc, Senior Vice President and Chief Financial Officer, Christian Marsolais, Ph.D., Senior Vice President and Chief Medical Officer, and John Leasure, Global Commercial Officer. This will be an excellent opportunity for participants to gain insights about the company’s recent developments and future endeavors.
Participation Details
Participants interested in joining the conference call are encouraged to log in at least ten minutes before the scheduled time to ensure smooth access. Important details about how to join the call, as well as information for future playback, will be shared during the session.
Conference Call Information
The conference call will occur on February 26, 2025, at 8:30 a.m. ET. Key information includes:
Dial-In Details:
- For toll-free access, dial 1-888-513-4119 or for international access, call 1-412-902-6615.
- Access code: 4430181.
Webcast Access
For convenience, Theratechnologies will offer a webcast option for participants who prefer an online format. The link to join the webcast will be provided prior to the call, ensuring easy access for all involved.
Replay and Accessibility
For those unable to attend, a replay of the conference call will be made available. The toll-free access for playback is provided at 1-877-344-7529 for the U.S. and Canada, and 1-412-317-0088 for international access. The replay will include access code: 3856571 and will be available until March 5, 2025.
About Theratechnologies
As a biopharmaceutical leader, Theratechnologies (Ticker: THTX) is dedicated to commercializing innovative treatments that enhance patient outcomes across various medical areas. Their commitment to advancing healthcare is paramount, and they continuously work on pioneering therapies that could redefine care standards. Interested individuals can find more information on the company's official website.
Frequently Asked Questions
1. What is the purpose of the upcoming conference call?
The conference call is meant to announce Theratechnologies' financial results and provide updates on current business developments.
2. Who will be presenting during the call?
Key executives including CEO Paul Lévesque and CFO Philippe Dubuc will present, along with other management members.
3. How can I access the conference call?
You can access the call by dialing the provided numbers or by joining through the webcast link that will be shared in advance.
4. When will the replay of the call be available?
The replay of the conference call will be accessible until March 5, 2025.
5. Where can I find more information about Theratechnologies?
Further information is available on the Theratechnologies website and on their official investor relations page.
About The Author
Contact Dominic Sanders privately here. Or send an email with ATTN: Dominic Sanders as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
